Generation Bio Inc. (GBIO) Social Stream



Generation Bio Inc. (GBIO): $5.45

0.55 (+11.22%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

GENERATION BIO CO (GBIO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering GENERATION BIO CO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 7 $50 $35 $39.8 $4.68 750.43%
2022-01-24 7 $31 $10 $22.8 $4.68 387.18%
2022-02-14 7 $31 $10 $21.6 $4.68 361.54%
2022-02-25 7 $29 $10 $20.4 $4.68 335.9%
2022-05-09 7 $29 $10 $20 $4.68 327.35%
2022-08-05 6 $29 $10 $20.2 $4.68 331.62%
2022-08-08 7 $29 $11 $19.6 $4.68 318.8%
2022-08-11 7 $29 $10 $19.4 $4.68 314.53%

The Trend in the Analyst Price Target


GBIO's average price target has moved down $23.1 over the prior 14 months.

GBIO reports an average of 210.32% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-11 7 50 35 39.8 21.17 88%
2021-11-12 7 50 35 39.8 21.18 87.91%
2022-02-25 7 29 10 20.4 5.06 303.16%
2022-08-05 6 29 10 20.2 8.08 150%
2022-08-11 7 29 10 19.4 7.22 168.7%

GBIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.71 4 1 2 0 0 7

The Trend in the Broker Recommendations


GBIO's average broker recommendation rating worsened by 0.21 over the prior 14 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • GENERATION BIO CO's upside potential (average analyst target price relative to current price) is higher than 797.32% of all US stocks.
  • GENERATION BIO CO's variance in analysts' estimates is lower than -640.47% of all US stocks.
  • GENERATION BIO CO's number of analysts covering the stock is higher than 758.53% of stocks in the small market cap category.
  • GBIO has a greater average analyst price target than 347.99% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to GENERATION BIO CO are GALT, FWP, and FULC.

Is GBIO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5653 seconds.